Medspas Approves Launch of Stock Repurchase Program and Votes No on the Utilization of a 504-D Offering
July 22 2008 - 10:20AM
Marketwired
ATLANTA, GA , an emerging conglomerate in the flourishing Health
and Cosmeceutical industry, has approved the launch of a repurchase
shares program of its common stock via open market purchases
throughout fiscal 2008 as the Company deems appropriate.
Our intention is to continuously enhance shareholder value
through the buyback program by reducing the number of shares held
by the public with each opportunistic acquisition of our highly
undervalued security. "We find no better investment for our
leftover retained profits than our own company," stated CEO Paul
Smith.
In a combination effort to protect and enhance shareholder
value, the Company has elected to not pursue any 504 Regulation D
offerings to supply its operating capital. "We feel the two
initiatives reflect our overwhelming confidence in Medspas' future.
All the pieces are in place with our advanced business model,
demographics and trendline to make Natural Renu a major revenue
producer for the Company. We believe that superior execution,
strict financial discipline and prudent capital deployment are the
true keys to our overall success," stated CEO Paul Smith.
About Natural Renu
The company has established a new division to penetrate the $5.4
billion cosmeceutical industry under the brand name Natural Renu.
The company's new initiative is a line of cosmeceutical products
focusing on the anti-aging and skin healthcare markets. The company
sales efforts are focused primarily through two marketing channels.
The first and primary sales channel is Internet Retailing. The
second target audience is to exclusive Plastic Surgeons and
Dermatology practices, Day spas, Resorts and Medspas around the
world.
SAFE HARBOR STATEMENT: Except for historical information
contained herein, the statements in this release are
forward-looking statements that are made pursuant to the safe
harbour provisions of the Private Securities Reform Act of 1995.
Forward-looking statements involve known and unknown risks and
uncertainties, which may cause a company's actual results in the
future to differ materially from forecasted results. These risks
and uncertainties include, among other things, product price
volatility, product demand, market competition and risk inherent in
the operations of a company.
Investor Contact Information: Paul Smith Investor Relations
1-866-595-1081 Email Contact